冠福控股股份有限公司2023年半年度非经营性资金占用及其他关联资金往来情况汇总表 | 编制单位：冠福控股股份有限公司 | | | | | | | | | 单位：元 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公司的关联 | 上市公司核算 | 2023年期初占用 | 2023年半年度占用累 计发生金额（不含利 | 2023年半年度占 2023年半年度 用资金的利息(如 偿还累计发生 | 2023年6月末占用 | 占用形成原因 | 占用性质 | | | | 关系 | 的会计科目 | 资金余额 | | | | 资金余额 | | | | | | | | 息） | 有) 金额 | | | | | 控股股东、实际控制人及其 | | | | | | | | | | | 附属企业 | | | | | | | | | | | 小计 | | | | | | | | | | | 其他关联方及其附属企业 | 林氏家族 | 过去12个月内曾持有公 | 其他应收款 | 1,012,476,792. ...

证券代码：002102 证券简称：冠福股份 公告编号：2023-046 冠福控股股份有限公司 第七届董事会第十一次会议决议公告 特此公告。 1 冠福控股股份有限公司 董 事 会 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 冠福控股股份有限公司（以下简称"公司"、"本公司"）第七届董事会第十 一次会议采取通讯表决的方式于 2023 年 8 月 18 日上午召开。本次会议由公司董 事长陈烈权先生召集和主持，会议通知已于 2023 年 8 月 8 日以专人递送、传真、 电子邮件等方式送达全体董事、监事和高级管理人员。本次会议应参加会议的董 事九人（发出表决票九张），实际参加会议的董事九人（收回有效表决票九张）。 本次会议的召集、召开符合《中华人民共和国公司法》和《公司章程》的有关规 定。 一、以 9 票赞成、0 票反对、0 票弃权的表决结果审议通过《2023 年半年度 报告及其摘要》。 《冠福控股股份有限公司 2023 年半年度报告》和《冠福控股股份有限公司 2023 年 半 年 度 报 告 摘 要 》 详 见 公 司 指 定 信 息 披 露 网 站 巨 潮 资 ...

本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 冠福控股股份有限公司（以下简称"公司"、"冠福股份"）第七届监事会第 九次会议于 2023 年 8 月 18 日上午以通讯表决方式召开。本次会议由公司监事会 主席陈勇先生召集，会议通知已于 2023 年 8 月 8 日以专人递送、传真和电子邮 件等方式送达全体监事。应参加会议的监事三人（发出表决票三张），实际参加 会议的监事三人（收回有效表决票三张）。本次会议的召集、召开符合《中华人 民共和国公司法》和《公司章程》的有关规定。 证券代码：002102 证券简称：冠福股份 公告编号：2023-047 经与会监事认真审议，本次会议以记名投票表决方式表决通过了以下决议： 冠福控股股份有限公司 第七届监事会第九次会议决议公告 《冠福控股股份有限公司 2023 年半年度报告》和《冠福控股股份有限公司 2023 年 半 年 度 报 告 摘 要 》 详 见 公 司 指 定 信 息 披 露 网 站 巨 潮 资 讯 网 （http://www.cninfo.com.cn）或《证券时报》《中国证券报》《上海证券报》《证券 日报》。 特 ...

证券代码：002102 证券简称：冠福股份 公告编号：2023-048 冠福控股股份有限公司 关于以债权转股权方式对全资子公司进行增资的公告 3、住所：陕西省安康市汉滨区兴安中路 62 号广场大厦 D 座 902 室 4、法定代表人：龚新文 5、注册资本：3,000 万元人民币 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或者重大遗漏。 一、本次增资情况概述 1、冠福控股股份有限公司（以下简称"冠福股份""公司"）根据战略发展和 业务整合的需要，拟以债权转股权的方式对全资子公司陕西省安康燊乾矿业有限公 司（以下简称"燊乾矿业"）增资 5,789.69 万元人民币（币种下同），其中 1,000 万 元计入燊乾矿业的注册资本，其余 4,789.69 万元计入燊乾矿业的资本公积。本次增 资完成后，燊乾矿业注册资本由 3,000 万元增加至 4,000 万元，仍为公司全资子公司。 2、交易属于公司合并报表范围内对全资子公司的增资事项，不构成关联交易， 亦不构成《上市公司重大资产重组管理办法》规定的重大资产重组。 3、交易已经公司第七届董事会第十一次会议审议批准，无需提交公司股东 ...

冠福控股股份有限公司 独立董事关于公司控股股东及其他关联方占用公司资金和 公司对外担保情况的专项说明和独立意见 一、关于公司控股股东及其他关联方占用公司资金情况的专项说明和独立 意见 截至报告期末，因以往年度林氏家族违规等事项形成林氏家族及其关联方 非经营性占用公司资金，除此之外，公司控股股东不存在占用公司资金的情况， 公司与其他关联方发生的资金往来属于正常的经营性关联交易，均能遵守《上 市公司监管指引第 8 号——上市公司资金往来、对外担保的监管要求》（证监 会公告[2022]26 号）和深圳证券交易所的相关规定，交易程序合法，定价公允， 不存在关联方违规占用公司资金的情况，符合相关规范性文件的规定。 截至 2023 年 6 月 30 日，本公司及子公司经审批的对外担保额度为 387,280.50 万元，占本公司 2022 年 12 月 31 日经审计归属于上市公司股东的净 资产 386,314.83 万元的 100.25%，其中：公司对外提供担保额度为 114,000.00 万元，公司为子公司提供担保额度为 272,030.50 万元，子公司为子公司提供担 保额度为 1,250.00 万元。 冠福控股股份 ...

冠福控股股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | |--------------------|-------------------------|------------------------------------------------|-----------------| | | | 编号：2023-001 | | | | ■特定对象调研 | □分析师会议 | | | | □媒体采访 | □业绩说明会 | | | 投资者关系活动类别 | □新闻发布会 | □路演活动 | | | | □现场参观 | | | | | □ | 其他（请文字说明其他活动内容） | | | | 1 | 、深圳前海明远睿达投资管理有限公司 | 吴巍 周珺 | | 活动参与人员 | 2、中信证券股份有限公司 | | 王喆 | | | 3、华鑫证券有限责任公司 | | 胡博新 | | 时间 | 2023 年 5 月 24 | 日星期三下午 14：00-17：00 | | | 地点 | 能特科技有限公司 | 荆州开发区深圳大道 | 118 号 | | 形式 | 现场走访 | | | | | ...

证券代码：002102 证券简称：ST 冠福 公告编号：2023-031 冠福控股股份有限公司 关于参加福建辖区上市公司 2023 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或者重大遗漏。 为进一步加强与投资者的互动交流，冠福控股股份有限公司（以下简称"公司"） 将参加由福建证监局、福建省上市公司协会与深圳市全景网络有限公司联合举办的 "2023 年福建辖区上市公司投资者网上集体接待日活动"，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP，参 与本次互动交流，活动时间为 2023 年 5 月 15 日（周一）16:00-17:30。届时公司高 管将在线就公司 2022 年度业绩、公司治理、发展战略、经营状况、融资计划、股权 激励和可持续发展等投资者关心的问题，与投资者进行沟通与交流，欢迎广大投资 者踊跃参与！ 特此公告！ 冠福控股股份有限公司 董 事 会 二○二三年五月十日 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥2,963,154,995.55, representing a 5.36% increase compared to ¥2,812,483,534.53 in the same period last year[3] - Net profit attributable to shareholders decreased by 25.88% to ¥85,422,238.32 from ¥115,251,288.22 year-on-year[3] - The company's basic earnings per share decreased by 26.03% to ¥0.0324 from ¥0.0438 in the same period last year[3] - Net profit for Q1 2023 was CNY 96,212,381.99, a decrease of 22.19% from CNY 123,685,307.11 in Q1 2022[24] - The company reported a total comprehensive income of CNY 96,261,845.23 for Q1 2023, compared to CNY 123,694,792.98 in Q1 2022, a decrease of 22.2%[24] Cash Flow - The net cash flow from operating activities was negative at -¥130,883,275.59, a decline of 534.36% compared to a positive cash flow of ¥30,132,613.90 in the previous year[3] - The company's net cash flow from operating activities for Q1 2023 was negative CNY 130,883,275.59, compared to a positive CNY 30,132,613.90 in Q1 2022[27] - The net cash flow from investment activities was -28,838,074.52, indicating a significant outflow of funds for investments[28] - The net cash flow from financing activities was 200,141,272.04, showing a positive cash position after financing outflows[28] - The company experienced a net increase in cash and cash equivalents of 40,367,423.40 during the quarter[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥8,779,263,773.54, down 4.05% from ¥9,149,758,633.36 at the end of the previous year[4] - The company's current liabilities totaled CNY 3,509,561,814.51, down from CNY 3,927,623,037.74 at the beginning of the year, indicating a reduction of approximately 10.6%[19] - The total liabilities decreased to CNY 4,667,740,579.77 in Q1 2023 from CNY 5,134,707,070.64 in Q1 2022, a reduction of 9.1%[20] - The total equity attributable to shareholders of the parent company increased to CNY 3,948,829,808.65 in Q1 2023 from CNY 3,863,148,321.27 in Q1 2022, reflecting a growth of 2.22%[20] Investments and Expenses - The company reported a 220.04% increase in financial expenses, primarily due to increased interest expenses on bank loans[9] - Research and development expenses increased to CNY 17,312,352.76 in Q1 2023, compared to CNY 15,111,897.05 in Q1 2022, marking a growth of 14.6%[23] - The company reported a total cash outflow from investment activities of 28,842,274.52, reflecting ongoing investments in fixed and intangible assets[28] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 41,879[10] - The company has resolved all litigation cases related to the previous controlling shareholder's violations, and has applied to the Shenzhen Stock Exchange to lift the risk warning[15] - The company is actively working on measures to remove the risk warning and has been providing monthly updates on the progress[14] Other Financial Metrics - The weighted average return on equity fell to 2.19%, down 1.13% from 3.32% in the previous year[3] - The company experienced a 90.89% increase in construction in progress, indicating investment in new projects[9] - Contract liabilities increased by 44.81%, attributed to the rise in signed but unfulfilled contracts[9] - The cash and cash equivalents decreased to CNY 986,608,757.41 from CNY 1,001,472,432.92, reflecting a decline of about 1.5%[17] - Accounts receivable increased to CNY 480,107,322.36 from CNY 461,821,484.56, showing a growth of approximately 3.9%[17] - Inventory rose to CNY 1,694,778,018.79 from CNY 1,661,796,143.92, representing an increase of about 2%[18] - Short-term borrowings decreased significantly to CNY 552,557,209.13 from CNY 719,330,901.69, a reduction of approximately 23.2%[19] - The company reported a total of CNY 1,184,450,905.83 in fixed assets, slightly down from CNY 1,214,012,701.83 at the beginning of the year[18] - The long-term equity investments increased to CNY 589,542,972.24 from CNY 557,618,425.56, indicating a growth of approximately 5.7%[18] Audit and Reporting - The first quarter report was not audited, indicating that the figures presented are preliminary[29]

Financial Performance - The company's operating revenue for 2022 was approximately ¥12.26 billion, a decrease of 9.40% compared to ¥13.53 billion in 2021[29]. - Net profit attributable to shareholders for 2022 was approximately ¥444.48 million, representing a significant increase of 339.70% from ¥101.09 million in 2021[29]. - The net cash flow from operating activities for 2022 was approximately -¥738.52 million, a decline of 407.44% compared to ¥240.21 million in 2021[29]. - Basic earnings per share for 2022 were ¥0.1688, an increase of 339.58% from ¥0.0384 in 2021[29]. - Total assets at the end of 2022 were approximately ¥9.15 billion, a decrease of 2.25% from ¥9.36 billion at the end of 2021[29]. - Net assets attributable to shareholders at the end of 2022 were approximately ¥3.86 billion, an increase of 13.00% from ¥3.42 billion at the end of 2021[29]. - The company reported a significant non-recurring gain of ¥412.25 million in 2022, primarily due to the reversal of bad debt provisions[36]. - The total operating revenue for the company in 2022 was ¥12,260,290,469.99, a decrease of 9.40% compared to ¥13,532,557,657.25 in 2021[62]. - The pharmaceutical and chemical segment generated revenue of ¥1,020,111,225.06, representing 8.32% of total revenue, with an 18.48% increase from the previous year[62]. - The trading business accounted for ¥11,195,249,267.18, or 91.31% of total revenue, showing a decline of 11.29% from ¥12,619,586,362.55[62]. Asset Management - As of December 31, 2022, the goodwill balance was 1.538 billion yuan, accounting for 16.81% of total assets, indicating potential impairment risks if future acquisitions underperform[5]. - The company plans to sell non-core assets, including gold mining assets, to optimize its asset structure and improve operational efficiency[3]. - The company has completed an investment of 800 million yuan for the construction of a new production base for high-end pharmaceutical intermediates, achieving trial production and meeting production standards in 2022[54]. - The company plans to optimize its asset structure by selling non-core assets, including real estate and mining assets, to improve asset turnover and reduce the debt-to-asset ratio[59]. - The company has established a new subsidiary in Jingzhou, Hubei, to expand its business in the Central China region, aiming to create a new growth point[58]. Legal and Compliance Issues - The company has faced 574 investor lawsuits related to information disclosure violations, with an estimated liability of 46.1496 million yuan[8]. - The original controlling shareholder's family has incurred debts totaling 2.3656562 billion yuan, leading to ongoing legal disputes and potential recovery risks[6]. - The company reported uncertainty regarding its ability to continue as a going concern in the latest audit report[29]. - The company has judicially frozen 1,255,800 shares in its repurchase account due to legal actions against the former controlling shareholder[86]. - A total of 5 bank accounts, including 1 basic deposit account and 4 general settlement accounts, have been frozen, with a total amount of 336,088.46 yuan, representing 0.01% of the company's latest audited net assets[86]. - The company has faced administrative penalties from the China Securities Regulatory Commission, including fines of 50,000 yuan for several individuals due to information disclosure violations[136]. Operational Risks and Management - The company acknowledges operational risks due to a lack of technical talent and management experience in its mining operations[3]. - The company emphasizes the importance of retaining core technical personnel to ensure long-term development and innovation[5]. - The company is committed to maintaining a robust risk control framework amid increasing operational complexities[4]. - The company has established a comprehensive human resource management and incentive mechanism to mitigate the risk of core personnel turnover[5]. - The company is focusing on both organic growth and external acquisitions to diversify its business operations[4]. Research and Development - The company’s R&D capabilities are strong, focusing on key intermediates like Montelukast sodium and Rosuvastatin series intermediates, maintaining a competitive position in the global market[42]. - Research and development expenses increased by 22.04% to CNY 77,937,187.20, representing 0.64% of total revenue[74]. - The company has been actively involved in the development of new products and technologies, although specific details were not provided in the extracted content[118]. - The company is focusing on technological innovation to further optimize and upgrade its B2B platform, integrating various services into a comprehensive ecosystem[57]. Corporate Governance - The company strictly adheres to legal regulations and governance standards, ensuring transparency and protecting investor rights, particularly for minority shareholders[103]. - The board of directors operates independently, with no interference from major shareholders, maintaining a clear separation in business, personnel, assets, and finances[104]. - The performance evaluation and incentive mechanisms for directors and senior management are transparent and fair, aligning with legal requirements and company bylaws[105]. - The company has established a robust internal audit system to ensure compliance and effective internal controls, enhancing operational transparency[107]. - The company actively engages in investor relations, providing transparent communication channels to enhance investor confidence[106]. Environmental Responsibility - The company has established a wastewater treatment facility with a processing capacity of 200 tons per day, utilizing a multi-step treatment process to ensure compliance with discharge standards[171]. - The total amount of COD emissions is 0.212 tons per year, significantly below the approved limit of 2.04153 tons per year[170]. - The company has paid an environmental protection tax of 413,500 yuan during the reporting period[176]. - The company has implemented an online monitoring system for wastewater discharge, ensuring continuous compliance with environmental standards[175]. - The company has conducted emergency drills for environmental incidents annually, ensuring preparedness for potential environmental emergencies[173]. Strategic Initiatives - The company is focusing on market expansion strategies, but specific metrics or targets were not detailed in the provided documents[118]. - The company is exploring potential partnerships to enhance its technological capabilities, which could lead to new revenue streams in the future[130]. - The company is committed to improving operational efficiency to drive profitability in the upcoming fiscal year[193]. - The company is actively pursuing partnerships and collaborations to strengthen its market position[194]. Shareholder Engagement - The company held five temporary shareholder meetings in 2022, with participation rates ranging from 4.33% to 33.19%[111]. - The company’s board of directors includes members with varying ages, from 34 to 62 years old[113]. - The company has a total of 60.42 million shares held by its directors and supervisors at the end of the reporting period[115]. - The company has maintained a consistent governance structure with regular board meetings and oversight[141].

证券代码：002102 证券简称：ST 冠福 公告编号：2023-020 冠福控股股份有限公司 冠福控股股份有限公司 董 事 会 二○二三年四月十八日 - 1 - （问题征集专题页面二维码） 特此公告。 关于举行 2022 年度报告业绩说明会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 冠福控股股份有限公司（以下简称"公司"）于 2023 年 4 月 18 日在巨潮资 讯网披露了《冠福控股股份有限公司 2022 年度报告》和《冠福控股股份有限公司 2022 年度报告摘要》，公司定于 2023 年 5 月 5 日（星期五）15:00-17:00 在全景 网提供的网上平台举行 2022 年度报告网上业绩说明会。本次年度报告业绩说明会 将 采 用 网 络远 程 的 方式 举 行 ，广 大 投 资者 可 登录 " 全 景· 路 演 天下 " （https://rs.p5w.net）参与公司本次年度业绩说明会。 出席本次业绩说明会的人员有：公司董事长陈烈权先生、董事兼董事会秘书 黄浩先生、董事构旭荣女士、独立董事梅平先生、总经理姚晓琴先生、财务总监 詹 ...